Guselkumab for previously treated moderately to severely active Crohn's disease

  • Technology appraisal guidance
  • TA1095
  • Published: 

Register as a stakeholder

History

Documents created during the development process.

Final draft guidance

Invitation to participate

Invitation to participate

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6238